Rasna Therapeutics Stock Today
| RASP Stock | USD 0 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Rasna Therapeutics is selling at 0.004 as of the 27th of November 2024; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 0.004. Rasna Therapeutics has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Rasna Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of May 2023 and ending today, the 27th of November 2024. Click here to learn more.
Rasna Therapeutics, Inc., a leukemia-focused biotechnology company, engages in developing therapeutics for the treatment of acute myeloid leukemia and other forms of leukemia and lymphoma. Rasna Therapeutics, Inc. was founded in 2013 and is headquartered in New York, New York. The company has 771.81 M outstanding shares. More on Rasna Therapeutics
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Rasna Pink Sheet Highlights
| Business Concentration | null, null, Biotechnology, Healthcare (View all Sectors) |
Rasna Therapeutics [RASP] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.04 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Rasna Therapeutics's market, we take the total number of its shares issued and multiply it by Rasna Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Rasna Therapeutics conducts business under null sector and is part of null industry. The entity has 771.81 M outstanding shares.
Rasna Therapeutics currently holds about 10.52 K in cash with (312.66 K) of positive cash flow from operations.
Check Rasna Therapeutics Probability Of Bankruptcy
Ownership AllocationRasna Therapeutics owns a total of 771.81 Million outstanding shares. Rasna Therapeutics holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 85.1 pct. of Rasna Therapeutics outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Rasna Ownership Details
Rasna Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Rasna Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Additional Tools for Rasna Pink Sheet Analysis
When running Rasna Therapeutics' price analysis, check to measure Rasna Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rasna Therapeutics is operating at the current time. Most of Rasna Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rasna Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rasna Therapeutics' price. Additionally, you may evaluate how the addition of Rasna Therapeutics to your portfolios can decrease your overall portfolio volatility.